Comparison of the effects of telmisartan, spironolactone and their combination in the prevention of left ventricular remodeling after acute myocardial infarction in the rats

陈国忠,傅国胜,赵志宏,于路
DOI: https://doi.org/10.3969/j.issn.1008-7664.2006.07.004
2006-01-01
Abstract:Objectives To compare the effects of telmisartan ,selective angiotensin Ⅱ type 1 receptor blocker (ARB) and spironolactone, aldosterone blocker (AB) on the left ventricular (LV) remodeling after acute myocardial infarction (AMI) in the rats. Methods AMI was induced in male SD rats by ligating the left coronary artery. Twenty-four hours after the procedure, the 72 surviving rats were randomly divided into four groups (1) AMI controls ,(2) telmisartan,(3) spironolactone ,(4) concomitant telmisartan and spironolactone groups; and (5) sham-operated group to serve as noninfarction controls. At 6 weeks after AMI, hemodynamic studies and pathologic analysis were performed in each group.Results There were no significant differences among the four AMI groups in MI size (P>0.05). Left ventricular end diastolic pressures (LVEDP), LV weight, interventricular septal (IVS) thickness, LV cross-section in-perimeter (LVSPM) in the telmisartan and two drugs combining group were significantly reduced (P<0.05~0.001),while in spironolactone group ,only LVEDP was reduced .Collagen volume fractions(CVFs) in the non-infarcted zone (NIZ) were significantly reduced in the telmisartan, spironolactone and two drugs combination treatment group (P<0.001).Additionally, there was no significant difference in all indicators as stated above between telmisartan and two drugs combining group. Conclusion Telmisartan can effectively reduce LVEDP and prevent LV remodeling after AMI in rats . There are no additive effect in preventing LV remodeling after AMI in rats when the drugs are used in combination. Spironolacton can significantly reduce collagen contents in noninfarcted LV myocardium.
What problem does this paper attempt to address?